Mimicking liver disease and regeneration in vitro for drug development and liver transplantation

Publications

Prediction of Drug-Induced Hepatotoxicity Using Long-Term Stable Primary Hepatic 3D Spheroid Cultures in Chemically Defined Conditions

Auteurs: Sabine U Vorrink, Yitian Zhou, Magnus Ingelman-Sundberg, Volker M Lauschke
Publié dans: Toxicological Sciences, Numéro 163/2, 2018, Page(s) 655-665, ISSN 1096-6080
Éditeur: Oxford University Press
DOI: 10.1093/toxsci/kfy058

3D primary hepatocyte culture systems for analyses of liver diseases, drug metabolism and toxicity: Emerging culture paradigms and applications

Auteurs: Volker M. Lauschke, Reza Zandi Shafagh, Delilah F. G. Hendriks, Magnus Ingelman‐Sundberg
Publié dans: Biotechnology Journal, 2019, Page(s) 1800347, ISSN 1860-6768
Éditeur: Wiley - VCH Verlag GmbH & CO. KGaA
DOI: 10.1002/biot.201800347

Comparison of Hepatic 2D Sandwich Cultures and 3D Spheroids for Long-term Toxicity Applications: A Multicenter Study

Auteurs: Catherine C Bell, Anita C A Dankers, Volker M Lauschke, Rowena Sison-Young, Roz Jenkins, Cliff Rowe, Chris E Goldring, Kevin Park, Sophie L Regan, Tracy Walker, Chris Schofield, Audrey Baze, Alison J Foster, Dominic P Williams, Amy W M van de Ven, Frank Jacobs, Jos van Houdt, Tuula Lähteenmäki, Jan Snoeys, Satu Juhila, Lysiane Richert, Magnus Ingelman-Sundberg
Publié dans: Toxicological Sciences, Numéro 162/2, 2018, Page(s) 655-666, ISSN 1096-6080
Éditeur: Oxford University Press
DOI: 10.1093/toxsci/kfx289

AMP-activated protein kinase activation and NADPH oxidase inhibition by inorganic nitrate and nitrite prevent liver steatosis

Auteurs: Isabel Cordero-Herrera, Mikael Kozyra, Zhengbing Zhuge, Sarah McCann Haworth, Chiara Moretti, Maria Peleli, Mayara Caldeira-Dias, Arghavan Jahandideh, Han Huirong, Josiane de Campos Cruz, Andrei L. Kleschyov, Marcelo F. Montenegro, Magnus Ingelman-Sundberg, Eddie Weitzberg, Jon O. Lundberg, Mattias Carlstrom
Publié dans: Proceedings of the National Academy of Sciences, Numéro 116/1, 2019, Page(s) 217-226, ISSN 0027-8424
Éditeur: National Academy of Sciences
DOI: 10.1073/pnas.1809406115

Novel genetic and epigenetic factors of importance for inter-individual differences in drug disposition, response and toxicity

Auteurs: Volker M. Lauschke, Yitian Zhou, Magnus Ingelman-Sundberg
Publié dans: Pharmacology & Therapeutics, 2019, ISSN 0163-7258
Éditeur: Pergamon Press
DOI: 10.1016/j.pharmthera.2019.01.002

Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis

Auteurs: Tracey Hurrell, Vlasia Kastrinou-Lampou, Achilleas Fardellas, Delilah F. G. Hendriks, Åsa Nordling, Inger Johansson, Audrey Baze, Céline Parmentier, Lysiane Richert, Magnus Ingelman-Sundberg
Publié dans: Cells, Numéro 9/4, 2020, Page(s) 964, ISSN 2073-4409
Éditeur: MDPI
DOI: 10.3390/cells9040964

Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive models

Auteurs: Richard J. Weaver, Eric A. Blomme, Amy E. Chadwick, Ian M. Copple, Helga H. J. Gerets, Christopher E. Goldring, Andre Guillouzo, Philip G. Hewitt, Magnus Ingelman-Sundberg, Klaus Gjervig Jensen, Satu Juhila, Ursula Klingmüller, Gilles Labbe, Michael J. Liguori, Cerys A. Lovatt, Paul Morgan, Dean J. Naisbitt, Raymond H. H. Pieters, Jan Snoeys, Bob van de Water, Dominic P. Williams, B. Kevin Park
Publié dans: Nature Reviews Drug Discovery, Numéro 19/2, 2020, Page(s) 131-148, ISSN 1474-1776
Éditeur: Nature Publishing Group
DOI: 10.1038/s41573-019-0048-x

Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients

Auteurs: Line S. Bråten, Tore Haslemo, Marin M. Jukic, Magnus Ingelman-Sundberg, Espen Molden, Marianne K. Kringen
Publié dans: Neuropsychopharmacology, Numéro 45/3, 2020, Page(s) 570-576, ISSN 0893-133X
Éditeur: Nature Publishing Group
DOI: 10.1038/s41386-019-0554-x

CYP3A5 is unlikely to mediate anticancer drug resistance in hepatocellular carcinoma

Auteurs: Volker M Lauschke, Åsa Nordling, Yitian Zhou, Sara Fontalva, Isabel Barragan, Magnus Ingelman-Sundberg
Publié dans: Pharmacogenomics, Numéro 20/15, 2019, Page(s) 1085-1092, ISSN 1462-2416
Éditeur: Ashley Publications Ltd.
DOI: 10.2217/pgs-2019-0094

Mechanisms of Chronic Fialuridine Hepatotoxicity as Revealed in Primary Human Hepatocyte Spheroids

Auteurs: Delilah F G Hendriks, Tracey Hurrell, Julia Riede, Muriëlle van der Horst, Sarianna Tuovinen, Magnus Ingelman-Sundberg
Publié dans: Toxicological Sciences, Numéro 171/2, 2019, Page(s) 385-395, ISSN 1096-6080
Éditeur: Oxford University Press
DOI: 10.1093/toxsci/kfz195

Calcium Signaling in Liver Injury and Regeneration

Auteurs: Nuria Oliva-Vilarnau, Simona Hankeova, Sabine U. Vorrink, Souren Mkrtchian, Emma R. Andersson, Volker M. Lauschke
Publié dans: Frontiers in Medicine, Numéro 5, 2018, ISSN 2296-858X
Éditeur: Springer
DOI: 10.3389/fmed.2018.00192

The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids

Auteurs: Sebastian Prill, Andrea Caddeo, Guido Baselli, Oveis Jamialahmadi, Paola Dongiovanni, Raffaela Rametta, Kajsa P. Kanebratt, Arturo Pujia, Piero Pingitore, Rosellina Margherita Mancina, Daniel Lindén, Carl Whatling, Annika Janefeldt, Mikael Kozyra, Magnus Ingelman-Sundberg, Luca Valenti, Tommy B. Andersson, Stefano Romeo
Publié dans: Scientific Reports, Numéro 9/1, 2019, ISSN 2045-2322
Éditeur: Nature Publishing Group
DOI: 10.1038/s41598-019-47737-w

Three-Dimensional Spheroid Primary Human Hepatocytes in Monoculture and Coculture with Nonparenchymal Cells

Auteurs: Audrey Baze, Céline Parmentier, Delilah F.G. Hendriks, Tracey Hurrell, Bruno Heyd, Philippe Bachellier, Catherine Schuster, Magnus Ingelman-Sundberg, Lysiane Richert
Publié dans: Tissue Engineering Part C: Methods, Numéro 24/9, 2018, Page(s) 534-545, ISSN 1937-3384
Éditeur: Mary Ann Liebert Inc.
DOI: 10.1089/ten.tec.2018.0134

Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent

Auteurs: Céline Parmentier, Delilah F.G. Hendriks, Bruno Heyd, Philippe Bachellier, Magnus Ingelman-Sundberg, Lysiane Richert
Publié dans: Toxicology Letters, Numéro 295, 2018, Page(s) 187-194, ISSN 0378-4274
Éditeur: Elsevier BV
DOI: 10.1016/j.toxlet.2018.06.1069

Characterisation of the NRF2 transcriptional network and its response to chemical insult in primary human hepatocytes: implications for prediction of drug-induced liver injury

Auteurs: Ian M. Copple, Wouter den Hollander, Giulia Callegaro, Fiona E. Mutter, James L. Maggs, Amy L. Schofield, Lucille Rainbow, Yongxiang Fang, Jeffrey J. Sutherland, Ewa C. Ellis, Magnus Ingelman-Sundberg, Stephen W. Fenwick, Christopher E. Goldring, Bob van de Water, James L. Stevens, B. Kevin Park
Publié dans: Archives of Toxicology, Numéro 93/2, 2019, Page(s) 385-399, ISSN 0340-5761
Éditeur: Springer Verlag
DOI: 10.1007/s00204-018-2354-1

Clinically relevant CYP3A4 induction mechanisms and drug screening in 3D spheroid cultures of primary human hepatocytes

Auteurs: Delilah F.G. Hendriks, Sabine U. Vorrink, Tomas Smutny, Sarah C. Sim, Åsa Nordling, Shahid Ullah, Masaki Kumondai, Barry C. Jones, Inger Johansson, Tommy B. Andersson, Volker M. Lauschke, Magnus Ingelman‐Sundberg
Publié dans: Clinical Pharmacology & Therapeutics, 2020, ISSN 0009-9236
Éditeur: Nature Publishing Group
DOI: 10.1002/cpt.1860

Human hepatic 3D spheroids as a model for steatosis and insulin resistance

Auteurs: Mikael Kozyra, Inger Johansson, Åsa Nordling, Shahid Ullah, Volker M. Lauschke, Magnus Ingelman-Sundberg
Publié dans: Scientific Reports, Numéro 8/1, 2018, ISSN 2045-2322
Éditeur: Nature Publishing Group
DOI: 10.1038/s41598-018-32722-6

Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing

Auteurs: Volker M. Lauschke, Magnus Ingelman-Sundberg
Publié dans: European Journal of Pharmaceutical Sciences, Numéro 130, 2019, Page(s) 65-77, ISSN 0928-0987
Éditeur: Elsevier BV
DOI: 10.1016/j.ejps.2019.01.024

Recherche de données OpenAIRE...

Publications

Partager cette page

Télécharger